Should You Inhale?

For much of 2000, Inhale Therapeutic Systems (INHL) stock matched the 160% gains of the Nasdaq Biotech Index. By Dec. 29, Inhale had soared 168%, to 50 a share. But then the biotechs got pummeled. By Jan. 10, Inhale plummeted to 31. Fans of Inhale argue the drop provides a rare chance to snap up a stock that's set for another blast.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.